These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 2563896)

  • 1. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.
    TIMI Study Group
    N Engl J Med; 1989 Mar; 320(10):618-27. PubMed ID: 2563896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
    N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty.
    Passamani E; Hodges M; Herman M; Grose R; Chaitman B; Rogers W; Forman S; Terrin M; Knatterud G; Robertson T
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):51B-64B. PubMed ID: 2889758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty.
    Simoons ML; Arnold AE; Betriu A; de Bono DP; Col J; Dougherty FC; von Essen R; Lambertz H; Lubsen J; Meier B
    Lancet; 1988 Jan; 1(8579):197-203. PubMed ID: 2893037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.
    Rogers WJ; Baim DS; Gore JM; Brown BG; Roberts R; Williams DO; Chesebro JH; Babb JD; Sheehan FH; Wackers FJ
    Circulation; 1990 May; 81(5):1457-76. PubMed ID: 2110033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Bovill EG; Terrin ML; Stump DC; Berke AD; Frederick M; Collen D; Feit F; Gore JM; Hillis LD; Lambrew CT
    Ann Intern Med; 1991 Aug; 115(4):256-65. PubMed ID: 1906692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
    Circulation; 1994 Apr; 89(4):1545-56. PubMed ID: 8149520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.
    Roberts R; Rogers WJ; Mueller HS; Lambrew CT; Diver DJ; Smith HC; Willerson JT; Knatterud GL; Forman S; Passamani E
    Circulation; 1991 Feb; 83(2):422-37. PubMed ID: 1671346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators.
    Rogers WJ; Babb JD; Baim DS; Chesebro JH; Gore JM; Roberts R; Williams DO; Frederick M; Passamani ER; Braunwald E
    J Am Coll Cardiol; 1991 Apr; 17(5):1007-16. PubMed ID: 1901071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).
    Ruocco NA; Bergelson BA; Jacobs AK; Frederick MM; Faxon DP; Ryan TJ
    J Am Coll Cardiol; 1992 Dec; 20(7):1445-51. PubMed ID: 1452916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty.
    Guerci AD; Gerstenblith G; Brinker JA; Chandra NC; Gottlieb SO; Bahr RD; Weiss JL; Shapiro EP; Flaherty JT; Bush DE
    N Engl J Med; 1987 Dec; 317(26):1613-8. PubMed ID: 2960897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators.
    Hsia J; Hamilton WP; Kleiman N; Roberts R; Chaitman BR; Ross AM
    N Engl J Med; 1990 Nov; 323(21):1433-7. PubMed ID: 2122251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.
    Califf RM; Topol EJ; George BS; Boswick JM; Lee KL; Stump D; Dillon J; Abbottsmith C; Candela RJ; Kereiakes DJ
    Circulation; 1988 May; 77(5):1090-9. PubMed ID: 2966016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group.
    JAMA; 1988 Nov; 260(19):2849-58. PubMed ID: 2972848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study.
    Rogers WJ; Bourge RC; Papapietro SE; Wackers FJ; Zaret BL; Forman S; Dodge HT; Robertson TL; Passamani ER; Braunwald E
    Am J Cardiol; 1989 Mar; 63(9):503-12. PubMed ID: 2521976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial.
    Williams DO; Braunwald E; Knatterud G; Babb J; Bresnahan J; Greenberg MA; Raizner A; Wasserman A; Robertson T; Ross R
    Circulation; 1992 Feb; 85(2):533-42. PubMed ID: 1735149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group.
    Arnold AE; Simoons ML; Van de Werf F; de Bono DP; Lubsen J; Tijssen JG; Serruys PW; Verstraete M
    Circulation; 1992 Jul; 86(1):111-20. PubMed ID: 1617763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
    Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
    N Engl J Med; 1997 Jun; 336(23):1621-8. PubMed ID: 9173270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Barbash GI; Roth A; Hod H; Modan M; Miller HI; Rath S; Zahav YH; Keren G; Motro M; Shachar A
    Am J Cardiol; 1990 Sep; 66(5):538-45. PubMed ID: 2118299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.